SpaceX IPO is the biggest IPO in stock market history. Join the conversation.Click here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksJupiter Fund Management Regulatory News (JUP)

Share Price Information for Jupiter Fund Management (JUP)

Share Price is delayed by 15 minutes
Get Live Data
176.00    0.00 (0.00%)
Bid:
176.00
Ask:
176.60
Spread: 0.60 (0.341%)
Market Cap: £883.48m
JUP Live PriceLast checked at - London Stock Exchange

Intraday Jupiter Fund Management Share Chart

Stabilisation Notice

22 Apr 2020 09:45

RNS Number : 4905K
J.P. Morgan Securities PLC.
22 April 2020
 

22 Apr 20

Not for distribution, directly or indirectly, in or into the United States or any jurisdiction in which such distribution would be unlawful.

Jupiter Fund Management plc

Pre-stabilisation Period Announcement

J.P. Morgan Securities plc, (contact: Emma Lovett 0207 134 2468) hereby gives notice, as Stabilisation Coordinator, that the Stabilising Manager(s) named below may stabilise the offer of the following securities in accordance with Commission Delegated Regulation EU/xxx/2016 under the Market Abuse Regulation (EU/596/2016).

The securities:

Issuer:

Jupiter Fund Management plc

Guarantor (if any):

N/A

Aggregate nominal amount:

GBP tbc

Description:

GBP 10.25Y Non-Call 5Y Unsecured Unguaranteed Unsubordinated Tier 2 obligations of the Issuer

Listing: London Stock Exchange

Offer price:

TBC

Other offer terms:

Denoms: GBP 100,000 x GBP 1,000

Stabilisation:

Stabilisation Manager(s):

J.P. Morgan Securities plc (Stabilisation coordinator)

 

Stabilisation period expected to start on:

22 Apr 20

Stabilisation period expected to end no later than:

22 May 20

Existence, maximum size and conditions of use of overallotment facility:

The Stabilisation Manager(s) may over-allot the securities in an amount not exceeding 5% of the aggregate nominal amount stated above.

Stabilisation trading venue:

Over the counter, TBC

 

In connection with the offer of the above securities, the Stabilising Manager(s), or persons acting on behalf of the Stabilising Manager(s) may over-allot the securities, provided that the aggregate principal amount of the securities allotted does not exceed 105 percent of the aggregate principal amount of the securities, or effect transactions with a view to supporting the market price of the securities at a level higher than that which might otherwise prevail. However, stabilisation may not necessarily occur and any stabilisation action, if begun, may cease at any time, but it must end no later than the earlier of 30 days after the issue date of the securities and 60 days after the date of allotment of the securities.

This announcement is for information purposes only and does not constitute an invitation or offer to underwrite, subscribe for or otherwise acquire or dispose of any securities of the Issuer in any jurisdiction.

This announcement and the offer of the securities to which it relates are only addressed to and directed at persons outside the United Kingdom and persons in the United Kingdom who have professional experience in matters related to investments or who are high net worth persons within Article 12(5) of the Financial Services and Markets Act 2000 (Financial Promotion) Order 2005 and must not be acted on or relied on by other persons in the United Kingdom.

In addition, if and to the extent that this announcement is communicated in, or the offer of the securities to which it relates is made in, any EEA Member State that has implemented Directive 2003/71/EC (together with any applicable implementing measures in any Member State, the "Prospectus Directive") before the publication of a prospectus in relation to the securities which has been approved by the competent authority in that Member State in accordance with the Prospectus Directive (or which has been approved by a competent authority in another Member State and notified to the competent authority in that Member State in accordance with the Prospectus Directive), this announcement and the offer are only addressed to and directed at persons in that Member State who are qualified investors within the meaning of the Prospectus Directive (or who are other persons to whom the offer may lawfully be addressed) and must not be acted on or relied on by other persons in that in that Member State

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
STAEAPLAALDEEEA
Date   Source Headline
24th Mar 20255:30 pmRNSTransaction in Own Shares
21st Mar 20255:27 pmRNSTransaction in Own Shares
20th Mar 20255:19 pmRNSTransaction in Own Shares
19th Mar 20255:45 pmRNSTransaction in Own Shares
18th Mar 20255:17 pmRNSTransaction in Own Shares
17th Mar 20255:30 pmRNSTransaction in Own Shares
14th Mar 20256:00 pmRNSTransaction in Own Shares
14th Mar 202512:30 pmRNSRedemption of Subordinated Notes
13th Mar 20255:37 pmRNSTransaction in Own Shares
12th Mar 20255:55 pmRNSTransaction in Own Shares
11th Mar 20256:00 pmRNSTransaction in Own Shares
11th Mar 20254:00 pmRNSDirector Shareholding
10th Mar 20255:45 pmRNSTransaction in Own Shares
7th Mar 20255:30 pmRNSTransaction in Own Shares
6th Mar 20255:45 pmRNSTransaction in Own Shares
5th Mar 20255:30 pmRNSTransaction in Own Shares
5th Mar 20254:00 pmRNSDirector Shareholding
4th Mar 20256:25 pmRNSTransaction in Own Shares - Replacement
4th Mar 20255:35 pmRNSTransaction in Own Shares
3rd Mar 20255:35 pmRNSTransaction in Own Shares
3rd Mar 20254:30 pmRNSDirector Shareholding
3rd Mar 20252:10 pmRNSHolding(s) in Company
28th Feb 20257:30 amRNSNon-executive Director Changes
27th Feb 20257:00 amRNSAnnual Financial Report
27th Feb 20257:00 amRNSShare Buyback Programme
27th Feb 20257:00 amRNSIntention to Redeem Subordinated Notes
26th Feb 20255:00 pmRNSHolding(s) in Company
7th Feb 20251:36 pmRNSHolding(s) in Company
29th Jan 20258:19 amRNSHolding(s) in Company
21st Jan 20253:30 pmRNSHolding(s) in Company
17th Jan 20252:30 pmRNSHolding(s) in Company
10th Jan 202510:12 amRNSHolding(s) in Company
6th Jan 20253:00 pmRNSNon-executive Director Role Changes
20th Dec 20242:53 pmRNSHolding(s) in Company
18th Dec 20242:00 pmRNSDirector Shareholding
28th Oct 202411:51 amRNSHolding(s) in Company
25th Oct 20243:00 pmRNSHolding(s) in Company
25th Oct 202411:08 amRNSHolding(s) in Company
11th Oct 20247:00 amRNSTrading Update and Notice of Results
2nd Oct 20242:15 pmRNSHolding(s) in Company
30th Sep 202411:30 amRNSAppointment of a Non-Executive Director
27th Sep 202412:46 pmRNSHolding(s) in Company
13th Sep 202410:43 amRNSHolding(s) in Company
12th Sep 202412:00 pmRNSDirector/PDMR Shareholding
20th Aug 202410:24 amRNSHolding(s) in Company
19th Aug 20242:55 pmRNSHolding(s) in Company
12th Aug 20244:00 pmRNSNon-Executive Director - New External Role
1st Aug 20244:00 pmRNSHolding(s) in Company
26th Jul 20247:00 amRNSHalf-year Report
2nd Jul 20243:00 pmRNSNon-Executive Director - Change of External Role

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.